|
2026
|
P/S
|
Providing medical information regarding yeast infections and treatments for yeast infections. |
|
|
P/S
|
Pharmaceutical preparations for fungal infections; pharmaceutical preparations for the treatment ... |
|
2025
|
Invention
|
Triterpenoid antifungals for use in the treatment of mucormycosis. Enfumafungin derivative triter... |
|
2024
|
Invention
|
Antifungal agents with enhanced activity in acidic ph.
Enfumafungin derivative triterpenoid anti... |
|
|
Invention
|
Triterpenoid antifungals for the treatment of fungal osteo-articular infections.
Enfumafungin de... |
|
|
Invention
|
Injectable compositions of triterpenoid antifungals encapsulated in liposomes.
Injectable compos... |
|
2022
|
P/S
|
Pharmaceutical preparations for the treatment of yeast infections; anti-infectives; anti-fungal p... |
|
2021
|
Invention
|
Antifungal agents used in combination.
The present invention relates to the use of enfumafungin ... |
|
|
Invention
|
Novel salts and polymorphs of scy-078.
SCY-078 is a glucan synthase inhibitor with antimicrobial... |
|
2020
|
Invention
|
Lipid-based formulations of scy-078 salts. Invasive CandidiasisInvasive AspergillosisInvasive Asp... |
|
|
Invention
|
Antifungal agents for candida auris decolonization.
Enfumafungin derivative triterpenoid antifun... |
|
|
Invention
|
Antifungal agents for candida auris decolonization. Enfumafungin derivative triterpenoid antifung... |
|
|
Invention
|
Antifungal agents, like ibrexafungerp for candida auris decolonization. Candida aurisCandida auri... |
|
|
P/S
|
Antifungal pharmaceutical preparations; pharmaceutical preparations for the treatment of urovagin... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of infections, namely, fungal skin infections, vira... |
|
|
Invention
|
Pneumocystis spp. pneumonia. Pneumocystis spp. in in vivo models, exhibit adequate tissue penetra... |
|
|
Invention
|
Triterpenoid antifungals for the treatment or prevention of pneumocystis spp. pneumonia. Enfumafu... |
|
|
Invention
|
Pneumocystis spp. pneumonia. PneumocystisPneumocystisin vivoin vivo models, exhibit adequate tiss... |
|
|
Invention
|
Triterpenoid antifungals for the treatment of fungal osteo-articular infections. Enfumafungin der... |
|
2019
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations for the treatment of infections; anti-in... |
|
|
Invention
|
Salts and polymorphs of scy-078. SCY-078 is a glucan synthase inhibitor with antimicrobial activi... |
|
2018
|
Invention
|
Injectable compositions of triterpenoid antifungals encapsulated in liposomes. CandidaAspergillus... |
|
|
Invention
|
Injectable compositions of triterpenoid antifungals encapsulated in liposomes. Injectable composi... |
|
|
Invention
|
Antifungal agents with enhanced activity in acidic ph. Enfumafungin derivative triterpenoid antif... |
|
|
Invention
|
Antifungal agents with enhanced activity in acidic ph. Disclosed is the use of two dosage units f... |
|
|
Invention
|
Antifungal agents used in combination. The present invention relates to the use of enfumafungin d... |
|
2016
|
Invention
|
Novel salts and polymorphs of scy-078. SCY-078 is a glucan synthase inhibitor with antimicrobial ... |
|
2014
|
Invention
|
Antiparasitic compounds. The invention relates to 1,2,4 -thiadiazole derivatives and their use to... |
|
2013
|
Invention
|
Macrocycles.
Cyclosporin derivatives, methods of manufacturing the cyclosporin derivatives and m... |
|
|
Invention
|
Antiviral macrocycles.
Cyclosporin derivatives, methods of manufacturing the cyclosporin derivat... |
|
|
Invention
|
New antiviral macrocycles. Cyclosporin derivatives, methods of manufacturing the cyclosporin deri... |
|
2012
|
Invention
|
3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of h... |
|
|
Invention
|
Methods for the treatment and prevention of ocular disorders. 4 and Ak are as defined in the spec... |
|
|
Invention
|
Genetic markers associated with response to cyclophilin-binding compounds.
Methods of predicting... |
|
|
Invention
|
New uses of cyclophilin inhibitors. Methods of predicting the response in a patient infected with... |
|
2010
|
Invention
|
Novel cyclosporin analogues.
The invention relates to the use of cyclic compounds of general for... |
|
|
Invention
|
Cyclosporine analogues. The invention relates to the use of cyclic compounds of general formula (... |
|
|
Invention
|
Novel cyclic peptides. Compounds are disclosed of general formula (I) wherein A, B, R1 and R2 are... |
|
|
Invention
|
Novel cyclic peptides.
Compounds are disclosed of general formula (I):
Compounds are disclosed... |
|
|
Invention
|
Processes for isolation and purification of enfumafungin. The present disclosure relates to proce... |
|
|
Invention
|
Pharmaceutical compositions.
This invention relates to combinations comprising 3-[(R)-2-(N,N-dim... |
|
|
Invention
|
Combination of a cyclosporine derivative and nucleosides for treating hcv. This invention relates... |
|
|
Invention
|
Combination of a cyclosporine derivative and nucleosides for treating hcv.
This i... |
|
|
Invention
|
Cyclosporine derivative for use in the treatment of hcv and hiv infection.
Provided he... |
|
2008
|
Invention
|
Antifungal agents. Novel derivatives of enfumafungin are disclosed herein, along with their, phar... |
|
2005
|
P/S
|
Full line of pharmaceutical preparations and substances for human and veterinary use for the trea... |
|
|
P/S
|
Full line of pharmaceutical preparations and substances for human and veterinary use. Custom manu... |
|
|
P/S
|
House mark for a full line of pharmaceutical preparations and substances for human and veterinary... |
|
2003
|
P/S
|
[ Custom manufacture of chemicals and pharmaceuticals for others ] Pharmaceutical drug developmen... |
